Skip to main content
Clinical Trials/ISRCTN40152556
ISRCTN40152556
Completed
未知

Oral Rehydration therapy versus IntraVenous rehydration therapy in the first 12 hours following hospitalisation for hyperemesis gravidarum: a multicentre randomised controlled trial

niversity of Malaya Medical Centre0 sites124 target enrollmentDecember 6, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Hyperemesis gravidarum
Sponsor
niversity of Malaya Medical Centre
Enrollment
124
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

2024 Results article in https://doi.org/10.1002/ijgo.15429 (added 16/02/2024)

Registry
who.int
Start Date
December 6, 2020
End Date
January 6, 2023
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
niversity of Malaya Medical Centre

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged \=18 years
  • 2\. Confirmed pregnancy by urine pregnancy test and presence of intrauterine sac
  • 3\. Clinical diagnosis of hyperemesis gravidarum, with presence of ketonuria of at least 2\+ on admission
  • 4\. Gestation age less than 14 weeks
  • 5\. First hospital admission for hyperemesis gravidarum, and within 2 h of admission, where rehydration therapy has not formally been commenced

Exclusion Criteria

  • 1\. Allergy to oral rehydration salts
  • 2\. Women with an underlying medical disorder (including diabetes mellitus, hypertension, heart disease, renal disease, and endocrine disorder such as hyperthyroid disorder)
  • 3\. Multiple pregnancy
  • 4\. Proven non viable pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials